MENU
ARTH
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Arch Therapeutics (ARTH) Ownership - Who owns Arch Therapeutics?
Profile
Industry
N/A
Address
235 Walnut Street
Phone
+1 617 431-2313
Employees
8
Web
https://www.archtherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.02M
P/E Ratio
N/A
Total Cash
30.03K
Projected Growth
N/A
Total Debt
9.39M
Revenue
148.16K
Risk (Beta)
7.48
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
ARTH
Capitalization
1.02M
P/E Ratio
N/A
Risk (Beta)
7.48
Dividend Yield
N/A
Total Cash
30K
Total Cash/Share
0.01
Total Debt
9.39M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
148K
ROE
N/A
Book Value
-12.56M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-1.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4.44K
Current Ratio
0.10
Current Revenue Per Employee
3864.13
Dividends Per Share - Security
N/A
EBITDA
-8.68M
Float
N/A
Float - Current
N/A
Gross Income Margin
31.81
Revenue To Assets
-828.03
Shares Held By Institutions
0
Shares Outstanding - Current
4.44M
Total Liabilities
14M
Total Volume MTD
N/A
Value
-1
Gain YTD
-96.823
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
235 Walnut Street
Phone
+1 617 431-2313
Employees
8
Web
https://www.archtherapeutics.com